Stay updated on ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial
Sign up to get notified when there's something new on the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page.

Latest updates to the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page
- Check5 days agoChange DetectedThe history now includes a new revision entry v3.4.3. The previous revision v3.4.2 is removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history. The site-wide government funding notice was removed from the page.SummaryDifference0.8%

- Check41 days agoChange DetectedA government funding lapse notice was added along with the new revision label Revision: v3.4.1, and the previous revision label Revision: v3.4.0 was removed.SummaryDifference0.8%

- Check48 days agoChange DetectedUpdates on this page are primarily UI and documentation changes, including showing a glossary option, new color-coding cues (green for additions and red for deletions), and updated revision labels (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check62 days agoChange DetectedRevision: v3.3.4 was added to the record history and Revision: v3.3.3 was removed, updating the history for NCT02847624. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded revision entry v3.3.3 to the record history. Removed HHS Vulnerability Disclosure and revision v3.3.2 from the page.SummaryDifference0.2%

Stay in the know with updates to ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page.